DUBOIS-STRINGFELLOW NATHALIE (SVP-CHIEF DEVELOPMENT OFFICER) reported 2 transactions at SANGAMO THERAPEUTICS, INC
Review the transaction codes below to understand the nature of each event.
Filed: 2/26/2026ACC: 0001947007-26-000004
Officer· SVP-CHIEF DEVELOPMENT OFFICER
Since Feb 2026
-14.42K
Net shares
Net seller
$6.8K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
14.42K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−2.06K
Price / share
$0.47
Trade value
$974.77
% of position
0.3%
2/24/2026
693.13K→691.07K
Common Stock
Direct
Shares
−12.35K
Price / share
$0.47
Trade value
$5.81K
% of position
1.8%
2/25/2026
691.07K→678.71K
Total
Net shares
−14.42K
Net value
-$6.78K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/24/2026 | F · Tax Withholding | −2.06K | $0.47 | $974.77 | 0.3% | 693.13K | 691.07K |
| Common Stock Direct | 2/25/2026 | F · Tax Withholding | −12.35K | $0.47 | $5.81K | 1.8% | 691.07K | 678.71K |
| Total | −14.42K | -$6.78K | ||||||
Derivative Transactions0
No derivative transactions reported